

MCQOPTIONS
Saved Bookmarks
This section includes 233 Mcqs, each offering curated multiple-choice questions to sharpen your Control Systems knowledge and support exam preparation. Choose a topic below to get started.
101. |
Every web page has its own |
A. | database connection |
B. | personal search engine |
C. | animation scheme |
D. | url |
Answer» E. | |
102. |
What are presentations? |
A. | a sequence of slides that usually incorporate text, sound, graphics, and animation |
B. | a speech |
C. | information presented using more text than graphics and animation |
D. | a television interview or news report |
Answer» B. a speech | |
103. |
What is multimedia? |
A. | moving images and text |
B. | images and audio |
C. | integration of still and moving images, text, and sounds by means of computer technology |
D. | programs that combine text and images on a television screen |
Answer» D. programs that combine text and images on a television screen | |
104. |
………… is nothing but manner in which drug should be taken. |
A. | dosing frequency |
B. | dosage regimen |
C. | dose adjustment |
D. | none of the above |
Answer» C. dose adjustment | |
105. |
Which of the following is a characteristic of battery powered pumps? |
A. | Free flowing powders |
B. | The system is programmed to release drugs at a controlled rate |
C. | Control drug release by partitioning the drug from the oil |
D. | Administration of emulsions |
Answer» C. Control drug release by partitioning the drug from the oil | |
106. |
Dried reconstituted vesicles method is performed in |
A. | Solvent dispersion |
B. | Mechanical dispersion |
C. | Both a and b |
D. | none |
Answer» C. Both a and b | |
107. |
What are the characteristics of the mixed monolithic-reservoir devices? |
A. | The drug has a large therapeutic index |
B. | Drug permeation rate is high |
C. | The drug-polymer matrix is layered by rate-controlling membrane |
D. | Administration of emulsions |
Answer» D. Administration of emulsions | |
108. |
This is the equation for the calculation of creatinine clearance. Which age group does the Clcr = (140– Age) W / 72 * Scr formula belong to? |
A. | 1-6 years |
B. | 1-20 years |
C. | Males above 20 years |
D. | Females above 20 years |
Answer» D. Females above 20 years | |
109. |
Liposomes have solubility |
A. | Lower |
B. | Higher |
C. | Both a and b |
D. | None |
Answer» B. Higher | |
110. |
Liposomes have half life |
A. | Longer |
B. | Shorter |
C. | Intermediate |
D. | Both a and b |
Answer» C. Intermediate | |
111. |
What is the characteristic of dissolution controlled release systems? |
A. | Release the drug along the entire length of GIT |
B. | Prolonged their residence in the GIT and release |
C. | Release only at a specific drug |
D. | Very slow dissolution rate |
Answer» E. | |
112. |
The duration of action of parental controlled release systems can be extended up to what time? |
A. | 1 day |
B. | 1 week |
C. | 1 month |
D. | Day, week, month even a year |
Answer» E. | |
113. |
What is the characteristic of encapsulation or coating dissolution-controlled release systems? |
A. | Microencapsulation using slowly dissolving materials |
B. | Prolonged their residence in the GIT and release |
C. | Release only at a specific drug |
D. | Employ waxes to control the rate of dissolution |
Answer» B. Prolonged their residence in the GIT and release | |
114. |
A suspension shows zero-order kinetic with a rate constant 2mg/ml.month. The dose of suspension is20mg/ml. The biological half life of the above dosage form is |
A. | 5 months |
B. | 1 month |
C. | 3 months |
D. | 2 months |
Answer» B. 1 month | |
115. |
What is the characteristic of delayed release systems? |
A. | Release the drug along the entire length of GIT |
B. | Prolonged their residence in the GIT and release |
C. | Release only at a specific drug |
D. | Release as soon as comes in contact to the saliva |
Answer» D. Release as soon as comes in contact to the saliva | |
116. |
Which of the following is a characteristic of the parental controlled drug release system byliposomes? |
A. | Free flowing powders |
B. | Aqueous solutions |
C. | Lipid bilayer enclosing the drug |
D. | Administration of emulsions |
Answer» D. Administration of emulsions | |
117. |
What are the characteristics of reservoir devices-controlled release systems? |
A. | Release the drug along the entire length of GIT |
B. | Drug disperse in the insoluble matrix of rigid hydrophobic materials |
C. | Hollow systems containing drug surrounded by a polymer membrane |
D. | Employ waxes to control the rate of dissolution |
Answer» D. Employ waxes to control the rate of dissolution | |
118. |
Liposomes consists of a bilayer of |
A. | Hydrophilic molecules |
B. | Hydrophobic molecules |
C. | Both a and b |
D. | None |
Answer» D. None | |
119. |
Which one of the following should not be a characteristic of the vehicles or polymers which are usedfor parenteral formulations? |
A. | Sterile |
B. | Consists of pyrogen |
C. | Nonirritating |
D. | Biodegradable |
Answer» C. Nonirritating | |
120. |
To have a plasma distribution value of 900 ml and plasma drug concentration to be 1.2 mg/ml whatshould be the amount of drug that should be given to the patient? |
A. | 1080 ml |
B. | 1080 g |
C. | 1080 mg |
D. | 1g/ml |
Answer» D. 1g/ml | |
121. |
Which of the following is a false statement for vapour pressure pump? |
A. | The device consists of two chambers |
B. | A chamber contains the drug solution |
C. | Drug solution chamber is separated by rigid walls |
D. | Vapour chamber contains vaporizable fluids |
Answer» D. Vapour chamber contains vaporizable fluids | |
122. |
What are the characteristics of continuous release systems? |
A. | Release the drug along the entire length of GIT |
B. | Prolonged their residence in the GIT and release |
C. | Release only at a specific drug |
D. | Release as soon as comes in contact to the saliva |
Answer» C. Release only at a specific drug | |
123. |
A girl with age 21 has height 240cm, weight 55kg, serum creatinine of 0.8mg will have______________ creatinine clearance. |
A. | 80 ml/min |
B. | 90 ml/min |
C. | 96.25 ml/min |
D. | 85 ml/min |
Answer» D. 85 ml/min | |
124. |
After implantation of a vapour pressure pump, the body has to get heated by exercising so that thevolatile liquid vaporizes. |
A. | True |
B. | False |
C. | none |
D. | all |
Answer» C. none | |
125. |
Which is the disadvantage for implants? |
A. | More effective |
B. | More prolonged action |
C. | Significantly small dose |
D. | Need of microsurgery |
Answer» E. | |
126. |
Which of the following statement is true for osmotic pumps? |
A. | The tube is made up of stainless steel |
B. | The innermost is the drug reservoir in a no collapsible bag |
C. | The drug is contained a permeable polyester bag |
D. | The outer most cover is soft and easily permeable |
Answer» B. The innermost is the drug reservoir in a no collapsible bag | |
127. |
What are the characteristics of Matrix diffusion-controlled release systems? |
A. | Release the drug along the entire length of GIT |
B. | Drug disperse in an insoluble matrix of rigid hydrophobic materials |
C. | Release only at a specific drug |
D. | Employ waxes to control the rate of dissolution |
Answer» C. Release only at a specific drug | |
128. |
Enteric coating are used for which systems? |
A. | Intestinal release systems |
B. | Colonic release systems |
C. | Size based systems |
D. | Mucoadhesive systems |
Answer» B. Colonic release systems | |
129. |
Liposome phospholipids undergoes |
A. | Oxidation |
B. | Hydrolysis |
C. | Acetylation |
D. | Both a and b |
Answer» E. | |
130. |
Liposomes are spherical structures, usually between in diameter: |
A. | 80nm-100nm |
B. | 60nm-100nm |
C. | 55nm-1000nm |
D. | 15nm-1000nm |
Answer» E. | |
131. |
Oral controlled release drugs release the drug only inside the intestine. |
A. | True |
B. | False |
C. | none |
D. | all |
Answer» C. none | |
132. |
An adult male with age 22 has height 240cm, weight 85kg, serum creatinine of 0.8mg will have______________ creatinine clearance. |
A. | 150 ml/min |
B. | 160 ml/min |
C. | 170.13 ml/min |
D. | 174.131 ml/min |
Answer» E. | |
133. |
Which of the following should not be a property of implants? |
A. | Environmental stable |
B. | Biostable |
C. | Non-toxic |
D. | Nonremovable |
Answer» E. | |
134. |
This is the equation for the calculation of creatinine clearance. Which age group does the Clcr = 0.48H / Scr *[W/70]0.7 formula belong to? |
A. | 1-6 years |
B. | 1-20 years |
C. | Males above 20 years |
D. | Females above 20 years |
Answer» C. Males above 20 years | |
135. |
Which of the following statement is false for osmotic pumps? |
A. | The pump has three concentric circle |
B. | The innermost is the drug reservoir |
C. | The drug is contained a permeable polyester bag |
D. | Outer most rigid rate controlling semipermeable membrane |
Answer» D. Outer most rigid rate controlling semipermeable membrane | |
136. |
What is the drawback of parental controlled release systems? |
A. | Injecting is a difficulty |
B. | The drug cannot be easily removed once administered |
C. | Can get easily precipitated in the injection site |
D. | Rapid onset but fast excretion |
Answer» C. Can get easily precipitated in the injection site | |
137. |
What is the characteristic of matrix dissolution-controlled release systems? |
A. | Release the drug along the entire length of GIT |
B. | Prolonged their residence in the GIT and release |
C. | Release only at a specific drug |
D. | Employ waxes to control the rate of dissolution |
Answer» E. | |
138. |
What is the characteristics of floating or buoyant capsule systems? |
A. | Release the drug along the entire length of GIT |
B. | Granule drug with hydro gel |
C. | Release only at a specific drug |
D. | Use of high or low density pellets |
Answer» C. Release only at a specific drug | |
139. |
Temperature used for Ether Injection method is______ or under reduced pressure |
A. | 15-25 0C |
B. | 55-65 0C |
C. | 55-85 0C |
D. | None of the above |
Answer» C. 55-85 0C | |
140. |
Drugs cannot be delivered to the colon. |
A. | True |
B. | False |
C. | none |
D. | all |
Answer» C. none | |
141. |
What are the characteristics of hydrodynamic pressure controlled systems? |
A. | Buffering agents that adjust pH to the desired value |
B. | Drug disperse in an insoluble matrix of rigid hydrophobic materials |
C. | Generated by swelling hydrophilic hum |
D. | Formation of complexes between the drug and anion/cation exchange resins |
Answer» D. Formation of complexes between the drug and anion/cation exchange resins | |
142. |
Tip of sonicator is directly engrossed into liposome dispersion in |
A. | Bath sonication |
B. | Probe sonication |
C. | None of the above |
D. | all |
Answer» C. None of the above | |
143. |
Release of water-soluble drugs can be retarded by presenting it as ____________ suspension |
A. | Oil |
B. | Water |
C. | Colloidal |
D. | Freezing |
Answer» B. Water | |
144. |
What is the characteristic of delayed transit and continuous release systems? |
A. | Release the drug along the entire length of GIT |
B. | Prolonged their residence in the GIT and release |
C. | Release only at a specific drug |
D. | Release as soon as comes in contact to the saliva |
Answer» C. Release only at a specific drug | |
145. |
What is the characteristics of colonic release systems? |
A. | Release the drug along the entire length of GIT |
B. | Prolonged their residence in the GIT and release |
C. | Usage of polymers that dissolves only in the alkaline pH of colon |
D. | Use of enteric coating |
Answer» D. Use of enteric coating | |
146. |
The i.v. bolus dosage is 500mg and the plasma drug concentration is 0.8 mg/ml. What should be thevolume of distribution? |
A. | 625 mg/ml |
B. | 625 l |
C. | 625 ml |
D. | 0.0016 mg/ml |
Answer» D. 0.0016 mg/ml | |
147. |
What is the characteristic of pH-independent formulations? |
A. | Buffering agents that adjust pH to the desired value |
B. | Drug disperse in the insoluble matrix of rigid hydrophobic materials |
C. | Hollow systems containing drug surrounded by a polymer membrane |
D. | Formation of complexes between the drug and anion/cation exchange resins |
Answer» B. Drug disperse in the insoluble matrix of rigid hydrophobic materials | |
148. |
What are the characteristics of diffusion-controlled release systems? |
A. | Release the drug along the entire length of GIT |
B. | Diffusion of the dissolved drug |
C. | Release only at a specific drug |
D. | Employ waxes to control the rate of dissolution |
Answer» C. Release only at a specific drug | |
149. |
The resulting liposomes from French pressure cell extrusion are ______than sonicated SUVs |
A. | Smaller |
B. | Equal |
C. | Larger |
D. | all |
Answer» D. all | |
150. |
Subcutaneous tissue is an ideal location for implants? |
A. | True |
B. | False |
C. | none |
D. | all |
Answer» B. False | |